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SUMMARY
mTORC1 is a central signaling hub that integrates intra- and extracellular signals to regulate a 
variety of cellular metabolic processes. Mutations in regulators of mTORC1 lead to 
neurodevelopmental disorders associated with autism, which is characterized by repetitive, 
inflexible behaviors. These behaviors may result from alterations in striatal circuits that control 
motor learning and habit formation. However, the consequences of mTORC1 dysregulation on 
striatal neuron function are largely unknown. To investigate this, we deleted the mTORC1 negative 
regulator Tsc1 from identified striatonigral and striatopallidal neurons and examined how cell-
autonomous upregulation of mTORC1 activity affects their morphology and physiology. We find 
that loss of Tsc1 increases the excitability of striatonigral, but not striatopallidal, neurons and 
selectively enhances corticostriatal synaptic transmission. These findings highlight the critical role 
of mTORC1 in regulating striatal activity in a cell type- and input-specific manner, with 
implications for striatonigral pathway dysfunction in neuropsychiatric disease.
Graphical abstract
In Brief Benthall et al. demonstrate that postnatal deletion of the autism-risk gene Tsc1 causes 
cell-type-specific changes in striatal neuron morphology and physiology. They find that Tsc1 KO 
striatonigral, but not striatopallidal, neurons are hyperexcitable and have enhanced cortical 
excitatory synaptic transmission in the absence of changes to inhibition.
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INTRODUCTION
The mechanistic target of rapamycin (mTOR) signaling pathway is a central coordinator of 
cell growth and metabolism. Activation of mTOR complex 1 (mTORC1) signals anabolic 
processes via stimulation of protein synthesis, organelle biogenesis, and suppression of 
autophagy (Saxton and Sabatini, 2017). In the nervous system, mTORC1 controls neuronal 
output by regulating intrinsic excitability, synaptic transmission, and long-term synaptic 
plasticity in a cell-type-specific manner (Bateup et al., 2011, 2013; Tavazoie et al., 2005; 
Ehninger et al., 2008; Tsai et al., 2012; Normand et al., 2013; Yang et al., 2012). Tight 
regulation of mTOR signaling is essential, as its dysregulation is associated with a variety of 
neurological and psychiatric disorders (Costa-Mattioli and Monteggia, 2013; Lipton and 
Sahin, 2014). In particular, several neurodevelopmental disorders are caused by mutations in 
regulators of mTORC1. One of these, tuberous sclerosis complex (TSC), is caused by 
mutations in the TSC1 or TSC2 genes, which encode components of a protein complex that 
negatively regulates mTORC1 signaling (Crino et al., 2006). Loss of the TSC1/2 complex 
causes deregulated and constitutively active mTORC1, leading to a syndrome characterized 
by high rates of epilepsy, intellectual disability, and autism spectrum disorder (ASD) (Crino, 
2013; Curatolo et al., 2015). How dysregulated mTORC1 signaling causes these diverse 
phenotypes is not well understood, but current hypotheses suggest that mTOR-dependent 
alterations in neuronal excitability and synaptic balance cause aberrant circuit development 
and function.
The specific physiological phenotypes associated with mTORC1 deregulation are cell type 
dependent, indicating that the cellular context plays an important role in determining the 
outcome of mTOR pathway mutations. For example, in the hippocampus, loss of Tsc1 
impairs mGluR-dependent long-term depression and inhibitory synapse function, leading to 
network hyperactivity (Bateup et al., 2011, 2013; Ehninger et al., 2008; Weston et al., 2014). 
Mosaic deletion of Tsc1 from thalamic neurons alters their passive membrane properties and 
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action potential kinetics in an age-dependent manner (Normand et al., 2013). Loss of Tsc1 in 
the hypothalamus causes intrinsic hypoexcitability of Pomc- but not Agrp-expressing 
neurons (Yang et al., 2012). In the cerebellum, deletion of Tsc1 from Purkinje cells causes 
hypoexcitability and cell death, with no major effects on synaptic transmission (Tsai et al., 
2012). This diversity of responses to mTORC1 activation highlights the need to examine the 
consequences of mTOR signaling alterations in a cell-type- and circuit-specific manner.
Emerging evidence suggests that changes in the activity of striatal neurons may underlie the 
repetitive, inflexible behaviors associated with ASD (Fuccillo, 2016). The striatum is the 
main input structure of the basal ganglia, a group of subcortical nuclei that control action 
selection, motor learning, and habit formation (Graybiel, 2005; Graybiel and Grafton, 2015). 
The principal cells of the striatum are GABAergic spiny projection neurons (SPNs) that can 
be divided into two subtypes: striatonigral neurons of the direct pathway (dSPNs) that 
express type 1 dopamine receptors (D1) and striatopallidal neurons of the indirect pathway 
(iSPNs) that express type 2 dopamine receptors (D2) (Gerfen and Surmeier, 2011). Striatal 
SPNs are driven by glutamatergic inputs from the cortex and thalamus and project to distinct 
basal ganglia nuclei on the basis of their subtype (Smith et al., 1998; Kreitzer, 2009). 
Coordinated activity among ensembles of dSPNs and iSPNs determines basal ganglia output 
such that appropriate actions are selected while competing actions are suppressed (Mink, 
2003; Klaus et al., 2017). Disruptions in the balance of activity between dSPNs and iSPNs 
result in altered motor behaviors in a variety of neurological and psychiatric disorders 
(Gunaydin and Kreitzer, 2016; Kravitz et al., 2010; Bateup et al., 2010), including mouse 
models of ASD (Fuccillo, 2016). Despite the known involvement of mTOR signaling in 
ASD, both in TSC and in other forms of autism (Curatolo et al., 2010; Davis et al., 2015; 
Huber et al., 2015; Subramanian et al., 2015), the consequences of mTORC1 deregulation 
on striatal activity are largely unknown.
To elucidate the impact of TSC-mTOR signaling on striatal neuron function, we 
conditionally deleted Tsc1 from a subset of striatonigral and striatopallidal neurons and 
examined their morphological and physiological properties. We found that postnatal deletion 
of Tsc1 resulted in a cell-type-specific increase in dSPN excitability, mediated by changes in 
passive membrane properties, potassium channels, and dendritic morphology. In addition, 
loss of Tsc1 caused a selective enhancement of corticostriatal synaptic inputs onto dSPNs, 
with no major changes to thalamic or inhibitory synaptic transmission. These results indicate 
that increased excitability of dSPNs is a primary effect of deregulated TSC-mTOR signaling, 
which may lead to striatal circuit dysfunction by altering the balance of activity between 
dSPNs and iSPNs.
RESULTS
Upregulation of mTORC1 and Somatic Hypertrophy in SPNs with Tsc1 Deletion
To define the consequences of mTORC1 activation on striatal neuron function, we used a 
viral strategy to delete Tsc1 from a subset of neurons in the dorsolateral striatum. We 
injected dilute AAV5-Cre-mCherry or AAV5-Cre-GFP virus into the striatum of juvenile 
Tsc1fl/fl;D2-GFP or Tsc1fl/fl;D1-tdTomato mice, respectively, and performed experiments 
11–15 days later. This paradigm enabled fluorescence-based identification and subsequent 
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comparison of control (wild-type, WT) and Tsc1 knockout (Tsc1 KO) dSPNs and iSPNs in 
the same striatal slice (Figures 1A–1F and S1A–S1F). With this approach, we could isolate 
the cell-autonomous effects of mTORC1 deregulation, independent of developmental or 
compensatory alterations, as ~25% of cells in the injection area express Cre recombinase 
and the injection site is restricted to dorsal striatum (Figures S1G and S1H). In striatal 
sections, immunostaining with a phospho-antibody against the downstream mTORC1 
pathway target S6 (p-S6, Ser240/244) revealed an increase in mTORC1 activity in Tsc1 KO 
dSPNs and iSPNs compared with neighboring uninfected neurons (Figures 1B–1G and 
S1B–S1F). This confirms that Tsc1/2 complex function is impaired and mTORC1 is cell 
autonomously upregulated in Cre-expressing neurons.
A common phenotype associated with upregulation of mTORC1 signaling is somatic 
hypertrophy, which likely results from overactivation of mTORC1-regulated growth 
processes (Bateup et al., 2011; Meikle et al., 2007; Normand et al., 2013; Tavazoie et al., 
2005; Tsai et al., 2012). To investigate if striatal neurons display this phenotype, we 
reconstructed somata in three dimensions from histology sections and measured soma 
volume using the NeuN signal. Tsc1 KO dSPNs and iSPNs had significantly increased soma 
volume compared with controls (Figure 1H), consistent with previous findings. A significant 
difference in soma volume was also detected between dSPN and iSPN control cells, with 
dSPNs having slightly larger cell bodies (Figure 1H). We confirmed the effects of Tsc1 loss 
on soma size in a separate analysis of iSPNs in Tsc1fl/fl;D2-GFP mice using the GFP signal 
to measure soma volume (iSPN WT mean = 255.5 ± 2.4 μm3, iSPN KO mean = 291.8 ± 2.7 
μm3, p < 0.0001, Kolmogorov-Smirnov [K-S] test).
Intrinsic Excitability Is Selectively Enhanced in Tsc1 KO dSPNs
To understand how loss of Tsc1 affects striatal neuron function, we first investigated how 
intrinsic excitability is affected by Tsc1 deletion. We performed whole-cell current-clamp 
recordings of identified WT and Tsc1 KO dSPNs and iSPNs in striatal slices from 
Tsc1fl/fl;D2-GFP mice injected with AAV5-Cre-mCherry. Recordings for this and all 
subsequent experiments were performed from cells in the dorsolateral striatum. We injected 
a depolarizing current step (75–400 pA, 500 ms) and measured firing frequency as a 
function of current step amplitude. We observed the previously reported difference in 
frequency-current relationship between dSPN and iSPN control cells (Gertler et al., 2008), 
with iSPNs having significantly increased intrinsic excitability (Figures 2A and 2B; Table 
S1). Interestingly, we found a significant difference between dSPN WT and Tsc1 KO 
neurons, with dSPN KO cells firing at a higher rate in response to current injection (Figures 
2A and 2B; Table S1). Notably, no significant difference in frequency-current relationship 
was found between iSPN WT and KO neurons (Figures 2A and 2B).
As another measure of excitability, we determined the rheobase, the minimum current 
required to elicit a single action potential, by applying a series of depolarizing current steps 
in 10 pA increments (75–300 pA, 500 ms). Rheobase was significantly decreased in dSPN 
Tsc1 KO cells compared with controls, with no changes in Tsc1 KO iSPNs (Figure 2C). 
Lower rheobase current in Tsc1 KO dSPNs is consistent with increased excitability, as it 
indicates that less depolarization is required to evoke action potential firing. Consistent with 
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the enhanced excitability of Tsc1 KO dSPNs, membrane resistance was significantly 
increased and capacitance was significantly decreased compared with controls (Figures S1I 
and S1J). We found no differences in the passive properties of iSPN WT and Tsc1 KO cells 
(Figures S1I–S1K). Together these findings show that postnatal loss of Tsc1 selectively 
enhances the intrinsic excitability of dSPNs.
In addition to passive membrane properties, inwardly rectifying potassium channels (Kirs) 
are important for setting the membrane excitability of SPNs (Gertler et al., 2008; Kreitzer, 
2009; Shen et al., 2007). Previous work has shown that the excitability difference between 
SPN subtypes is associated with greater Kir current in dSPNs compared with iSPNs (Gertler 
et al., 2008). We therefore tested whether loss of Tsc1 affects Kir currents in striatal neurons. 
To activate potassium conductances, we applied a series of voltage steps (−150 to −60 mV, 
500 ms) in 10 mV increments in whole-cell voltage-clamp recordings. The predominant 
current in SPNs at hyperpolarized membrane potentials is through Kir channels; however, 
there is some contribution of leak conductances. To isolate Kir current, we blocked Kir 
channels with 1 mM CsCl and repeated the voltage step protocol. Kir currents were isolated 
from the Cs-insensitive leak conductances using digital subtraction (Figure 2D) (Cazorla et 
al., 2012). As previously reported (Gertler et al, 2008), Kir current was significantly larger in 
dSPN than iSPN control cells (Figures 2D and 2E; Table S1). Consistent with the enhanced 
intrinsic excitability of dSPN Tsc1 KO neurons, there was a significant decrease in Kir 
current in dSPN Tsc1 KO cells compared with controls (Figures 2D and 2E; Table S1). We 
also observed a small enhancement of Kir current at the most hyperpolarized membrane 
potential in Tsc1 KO iSPNs compared with WT iSPNs (Figures 2D and 2E; Table S1).
Dendritic Complexity Is Reduced in Tsc1 KO dSPNs
The degree of dendritic arborization strongly influences the membrane excitability of SPNs 
(Gertler et al., 2008). We therefore examined how dendritic morphology is affected by loss 
of Tsc1, as this could contribute to changes in excitability. Neurobiotin was dialyzed into 
cells during whole-cell recordings and visualized in fixed tissue sections using fluorophore-
conjugated avidin. Dendritic arbors were reconstructed in three dimensions (Figure 3A), and 
arborization was quantified by Sholl analysis. We found that the dendritic complexity of 
dSPN Tsc1 KO cells was significantly decreased compared with that of controls, while iSPN 
Tsc1 KO and control cells had a similar Sholl profile (Figures 3A–3C; Table S1). Consistent 
with these findings, total dendrite length was significantly decreased in dSPN Tsc1 KO cells, 
resulting from decreased dendrite branching (Figures 3D–3F; Tables S2 and S3). Similar to 
prior studies (Gertler et al., 2008), we found that dSPN control cells had significantly greater 
dendritic complexity, total dendritic length, number of primary dendrites, and branchpoints 
compared with iSPNs (Figures 3D–3F; Tables S2 and S3). Taken together, these results 
demonstrate that acute loss of Tsc1 and cell autonomous activation of mTORC1 signaling 
affects the intrinsic properties of dSPNs in multiple ways, with the net effect of enhancing 
their excitability.
Loss of Tsc1 Does Not Affect Synaptic Inhibition onto SPNs
mTORC1 is an important regulator of synaptic properties in several neuron types, and 
changes in synaptic function are thought to underlie mTOR-related disorders (Hoeffer and 
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Klann, 2010). For example, in hippocampal neurons, loss of Tsc1 and activation of 
mTORC1 increases the excitatory/inhibitory synaptic ratio because of a strong decrease in 
inhibitory synapse function (Bateup et al., 2013). To determine how loss of Tsc1 affects 
inhibition onto striatal neurons, we examined baseline inhibitory transmission by recording 
miniature inhibitory postsynaptic currents (mIPSCs) in Tsc1fl/fl;D2-GFP mice injected with 
AAV5-Cre-mCherry (Figure 4A). No differences in average mIPSC amplitude or frequency 
were observed with Tsc1 deletion in either SPN type (Figures 4B–4E). To determine 
whether loss of Tsc1 affects evoked inhibitory synaptic transmission, we recorded 
electrically evoked IPSCs in simultaneously recorded pairs of WT and Tsc1 KO dSPNs or 
iSPNs. We found no difference in IPSC amplitude between Tsc1 KO SPNs and controls 
(Figures 4F–4H). Because SPNs receive many sources of inhibition (Tepper et al., 2010) that 
could be differentially affected by Tsc1 deletion, we assayed inhibition in an input-specific 
manner. Fast-spiking parvalbumin-expressing interneurons (PV cells) control the activity of 
SPNs via feedforward inhibition (Koós and Tepper, 1999), and their dysfunction has been 
implicated in striatal-based disorders (Gittis and Kreitzer, 2012). To selectively activate 
inputs from PV cells, we bred the Tsc1fl/fl;D1-tdTomato mice to mice expressing optimized 
FLP recombinase (FlpO) under the Pvalb (parvalbumin) promoter (Pvalb-2A-FlpO-D; 
Madisen et al., 2010). Juvenile mice were injected with AAV5-fDIO-ChR2-EYFP (Fenno et 
al., 2014) and AAV5-Cre-GFP to selectively express channelrhodopsin (ChR2) in PV cells 
and delete Tsc1 from a subset of striatal neurons, respectively. We performed simultaneous 
paired recordings of Tsc1 KO and control dSPNs and activated PV cell inputs using full-
field optical stimulation (Figures 4I and 4J). We found no difference in the amplitude of 
optically evoked IPSCs (oIPSCs) between Tsc1 KO and control dSPNs (Figure 4K). 
Together these results show that acute, postnatal loss of Tsc1 does not strongly affect 
inhibitory synaptic function in SPNs.
Synaptic Excitation Is Selectively Increased in Tsc1 KO dSPNs
SPNs exhibit low baseline firing activity but are strongly driven by glutamatergic inputs 
(Wilson and Kawaguchi, 1996). To test whether loss of Tsc1 affects excitatory synaptic 
transmission in SPNs, we recorded miniature excitatory postsynaptic currents (mEPSCs) in 
Tsc1fl/fl;D2-GFP mice injected with AAV5-Cre-mCherry (Figure 5A). No difference in 
average mEPSC amplitude was found between conditions. However, the frequency of 
mEPSCs was selectively increased in dSPN Tsc1 KO cells compared with controls (Figures 
5B–5E). We verified that these results were not specific to the D2-GFP transgenic mouse 
line by repeating this experiment in Tsc1fl/fl;D1-tdTomato mice. Again, we found a selective 
increase in mEPSC frequency in Tsc1 KO dSPNs but not iSPNs (Figures S2A–S2C). 
Enhanced mEPSC frequency can result from either an increase in the number of excitatory 
synapses or an increase in presynaptic release probability. To test whether synapse number 
was affected by Tsc1 loss, we measured the density of dendritic spines, the sites of 
excitatory synapses onto SPNs, and found no difference between control and Tsc1 KO 
dSPNs (Figures S2D and S2E).
To determine whether loss of Tsc1 affects evoked excitatory synaptic transmission, we 
recorded electrically evoked EPSCs in simultaneously recorded pairs of WT and Tsc1 KO 
dSPNs or iSPNs (Figure 5F). Consistent with the mEPSC experiments, dSPN Tsc1 KO cells 
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had significantly larger EPSCs than controls (Figure 5G). No difference in EPSC amplitude 
was observed between iSPN WT and Tsc1 KO cells (Figure 5H). To test whether the 
increased EPSC amplitude and mEPSC frequency in Tsc1 KO dSPNs were due to changes 
in presynaptic release probability, we performed paired-pulse experiments and found a 
decrease in paired-pulse ratio in dSPN Tsc1 KO cells compared with controls, indicating 
enhanced presynaptic release probability (Figures 5I and 5J). No difference in the paired-
pulse ratio was observed between iSPN WT and Tsc1 KO cells (Figures 5I and 5K). These 
results demonstrate that loss of Tsc1 selectively alters excitatory/inhibitory synaptic balance 
in dSPNs via a strengthening of glutamatergic inputs without a concurrent change to 
GABAergic transmission.
Selective Enhancement of Corticostriatal Transmission onto Tsc1 KO dSPNs
The major excitatory inputs to the striatum arise from the cortex and thalamus (Kreitzer and 
Malenka, 2008), either or both of which could mediate the increased excitatory drive 
observed in Tsc1 KO dSPNs. Determining the source of the enhanced excitation is important 
for understanding its functional consequences, as thalamostriatal terminals are involved in 
attention and switching between tasks, whereas corticostriatal synapses are implicated in 
motor learning and habit formation (Graybiel, 2005; Graybiel and Grafton, 2015; Smith et 
al., 2011). To activate specific glutamatergic inputs, we expressed ChR2 (AAV5-ChR2-
mCherry) in either the thalamus or the cortex of Tsc1fl/fl; D1-tdTomato mice injected with 
AAV5-Cre-GFP into the striatum (Figures 6A and 6D). We measured input-specific synaptic 
responses in simultaneously recorded pairs of WT and Tsc1 KO dSPNs. In response to 
optical stimulation of thalamostriatal terminals, we found no difference in the amplitude of 
subthreshold excitatory postsynaptic potentials (oEPSPs) between control and Tsc1 KO 
dSPNs (Figures 6B and 6C). However, stimulation of cortical terminals resulted in 
significantly greater oEPSP amplitude in dSPN Tsc1 KO cells compared with WT, 
indicating that corticostriatal drive was selectively enhanced in Tsc1 KO dSPNs (Figures 6E 
and 6F).
To understand how stronger corticostriatal input could affect dSPN activity, we measured 
cortically driven action potentials (oAPs) in simultaneously recorded pairs of dSPN WT and 
Tsc1 KO cells in the absence of synaptic blockers. To achieve robust cortical ChR2 
expression sufficient to drive SPN firing, we bred Tsc1fl/fl;D1-tdTomato mice to mice 
expressing ChR2-YFP under the Thy1 promoter (Thy1-ChR2-YFP) (Arenkiel et al., 2007). 
Optical stimulation of corticostriatal terminals resulted in a significantly shorter latency to 
fire in Tsc1 KO dSPNs compared with simultaneously recorded controls (Figures 6G–6I). 
We also observed a trend toward decreased jitter in Tsc1 KO dSPNs (Figure 6J). These 
results demonstrate that loss of Tsc1 from dSPNs enhances corticostriatal transmission and 
alters their firing properties in response to cortical stimulation.
DISCUSSION
In this study, we determined how activation of mTORC1 signaling affects striatal physiology 
by deleting the mTORC1 negative regulator Tsc1 from a subset of neurons in the dorsal 
striatum. With this approach, we gained an understanding of how TSC-mTORC1 signaling 
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affects SPN morphology and function in a cell autonomous manner, independent of major 
network or developmental alterations. We found that the primary effect of Tsc1 loss was an 
increase in dSPN excitability with minimal effects on iSPNs. Both intrinsic and 
corticostriatal synaptic excitability were enhanced by deletion of Tsc1 from dSPNs without 
concurrent changes to synaptic inhibition or thalamostriatal excitation. The net effect of 
these changes was decreased latency of Tsc1 KO dSPNs to fire in response to cortical 
stimulation. These findings demonstrate that loss of Tsc1 and constitutive activation of 
mTORC1 signaling strongly affect the properties of direct pathway neurons such that 
cortical excitation is facilitated, with relatively little impact on neurons comprising the 
indirect pathway.
An interesting aspect of our study is the observed increase in dSPN, but not iSPN, intrinsic 
excitability due to postnatal loss of Tsc1. The increased excitability of Tsc1 KO dSPNs 
contrasts with the reduced excitability that has been observed in other cell types with Tsc1 
loss, including hippocampal CA1 neurons, thalamic neurons, and Purkinje cells (Bateup et 
al., 2013; Normand et al., 2013; Tsai et al., 2012). Compared with these cell types, we 
observed a relatively modest increase in soma size in Tsc1 KO SPNs (a 14% increase in 
SPNs versus a 41% increase in CA1 neurons with Tsc1 loss; Bateup et al., 2011). We also 
found that dendritic arborization was reduced in Tsc1 KO dSPNs. This decreased dendritic 
complexity likely has a stronger impact on the cell’s passive membrane properties than the 
small increase in soma size, leading to a net decrease in membrane capacitance and increase 
in resistance. These changes in passive membrane properties, together with the reduced Kir 
currents we observed, likely drive increased excitability in Tsc1 KO dSPNs. The fact that 
Tsc1 KO iSPNs showed a similar small increase in soma size as dSPNs but did not have 
major changes in dendritic morphology or Kir currents further indicates that these factors 
were responsible for the excitability changes in Tsc1 KO dSPNs. Notably, loss of Tsc1 has 
been shown to have cell-type-specific effects on the excitability of hypothalamic neurons, 
whereby Pomc-expressing Tsc1 KO neurons exhibit hypoexcitability but Agrp-expressing 
Tsc1 KO neurons show no change in excitability (Yang et al., 2012).
Cell-type-specific changes in intrinsic excitability and den-dritic morphology have been 
observed in SPNs in response to a variety of disease-related insults. For example, intrinsic 
excitability is increased and dendritic arborization is decreased in dSPNs but not iSPNs in L-
DOPA-induced dyskinesia, in which mTOR signaling is hyperactive (Fieblinger et al., 2014; 
Santini et al., 2009; Santini et al., 2012). Huntington’s disease mouse models are associated 
with low mTOR signaling and display altered potassium currents as well as iSPN-specific 
degeneration (Lee et al., 2015; Mitchell et al., 1999; Tong et al., 2014). The fact that 
phenotypes specific to either dSPNs or iSPNs are seen across mTOR-associated diseases is 
likely due to molecular differences between the two SPN subtypes. Although dSPNs and 
iSPNs are similar in many respects, they express distinct profiles of receptors and signaling 
molecules (Heiman et al., 2008), which will define their response to disease-related 
perturbations. Because the mTOR pathway integrates a variety of intra- and extracellular 
signals and shows extensive cross-talk with other signaling pathways, the outcomes of its 
activation are highly sensitive to the cellular context. Here we find no differences in the 
basal phosphorylation state of the mTORC1 pathway target S6 between dSPNs and iSPNs. 
In addition, Tsc1 loss elevated p-S6 levels to a similar extent in dSPNs and iSPNs. These 
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observations suggest that the core components of mTORC1 signaling are not different 
between dSPNs and iSPNs but that the consequences of mTORC1 activation on downstream 
pathways differs by cell type.
Changes in synaptic transmission are often, but not always (Tsai et al., 2012), observed in 
response to loss of Tsc1 (Tavazoie et al., 2005; Bateup et al., 2011, 2013; Weston et al., 
2014). In particular, a previous study showed that deletion of Tsc1 from hippocampal CA1 
neurons causes a loss of inhibitory synaptic transmission resulting in increased excitatory/
inhibitory synaptic ratio (Bateup et al., 2013). Changes in E/I balance are hypothesized to 
contribute to ASD pathophysiology (Rubenstein and Merzenich, 2003), and a recent study 
showed cell-type-specific alterations in excitatory/inhibitory (E/I) ratio in dSPNs resulting 
from mutations in the ASD-risk gene Nlgn3 (Rothwell et al., 2014). Here we found that 
synaptic E/I balance was also selectively altered in dSPNs following Tsc1 deletion; however, 
this was driven by an increase in excitatory synaptic drive without a change in inhibition. 
The downstream consequences of increased E/I ratio in dSPNs remain to be explored, but 
such a change is likely to increase the efficacy of the direct pathway to suppress basal 
ganglia output nuclei, thereby relieving their inhibition of downstream motor centers 
(Kravitz et al., 2010; Roseberry et al., 2016). Notably, corticostriatal synaptic transmission 
was selectively increased in Tsc1 KO dSPNs, while thalamostriatal transmission was 
unaltered. Similar increases in corticostriatal transmission have been observed in the 
Shank3B−/− mouse model of autism and in the Sapap3−/− mouse model of obsessive-
compulsive disorder (Peixoto et al., 2016; Wan et al., 2014), suggesting that enhanced 
corticostriatal activity in the dorsal striatum may be involved in the pathophysiology of 
multiple psychiatric disorders.
We found that the enhanced corticostriatal transmission in Tsc1 KO dSPNs was mediated by 
an increase in presynaptic release probability. This is supported by our observation of 
decreased paired-pulse ratio with no changes in mEPSC amplitude or dendritic spine 
density, which would indicate alterations in postsynaptic strength or synapse number, 
respectively. Because Cre expression was limited to striatal neurons in our model and the 
cortical inputs were WT for Tsc1, this suggests a change in retrograde signaling from SPN 
dendrites to cortical presynaptic terminals. Corticostriatal synapses are known to undergo 
endocannabinoid-dependent long-term depression (eCB-LTD), which is mediated by 
changes in presynaptic release probability (Surmeier et al., 2009). It is possible that 
deregulated mTORC1 signaling interferes with the production or release of retrograde 
signaling molecules from dSPNs, a direction that could be explored in future studies. Such a 
mechanism may also explain the input specificity of the phenotype, as thalamostriatal 
synapses do not undergo substantial eCB-LTD (Wu et al., 2015).
The relative timing of activation of the direct and indirect pathways is important for habit 
formation (O’Hare et al., 2016). For example, shorter latency of dSPNs to fire relative to 
iSPNs in response to cortical stimulation is correlated with preference to use more habitual 
strategies when learning an operant task (O’Hare et al., 2016). Interestingly, we found that 
Tsc1 deletion caused dSPNs to fire with reduced latency in response to cortical stimulation. 
Furthermore, there was a trend toward decreased action potential jitter in Tsc1 KO dSPNs 
across multiple stimulation trials, which could have implications for spike timing-dependent 
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plasticity (Shen et al., 2008). These results suggest that loss of Tsc1 and upregulation of 
mTORC1 in SPNs enhances cortical activation of the direct pathway. Future studies will 
determine if these cellular changes result in altered striatal-associated behaviors, with the 
goal of understanding how striatal dysfunction contributes to psychiatric disorders such as 
ASD.
EXPERIMENTAL PROCEDURES
Mice
Animal experiments were performed in accordance with protocols approved by the 
University of California, Berkeley, Animal Care and Use Committee. Male and female mice 
were used for all experiments. Please see Supplemental Experimental Procedures for a list of 
mouse lines used and a detailed description of the methods.
Stereotaxic Surgery
800nl of an AAV5 chicken b-actin promoter-driven Cre-mCherry or Cre-GFP virus (Penn 
Vector Core) was unilaterally injected into the dorsolateral striatum of postnatal day (P) 14–
16 Tsc1fl/fl;D2-GFP or Tsc1fl/fl;D1-tdTomato mice, respectively. Cre virus was diluted 20–
30 times in sterile saline to achieve sparse transduction. Mice were used for experiments 11–
15 days after Cre virus injection.
For the oIPSC experiments, Flp-dependent, Ef1a promoter-driven AAV5-fDIO-ChR2-EYFP 
virus (Fenno et al., 2014) was injected unilaterally into the dorsolateral striatum of P15–P17 
Tsc1;D1-tdTomato;Pvalb-2A-FlpO-D mice, followed by injection of AAV5-Cre-GFP at 
P34–P37. For oAP experiments, Tsc1fl/fl;D1-tdTomato;Thy1-ChR2-YFP mice were injected 
with AAV5-Cre-GFP into the dorsolateral striatum at P20–P27. For oEPSP experiments, 
CAG promoter-driven AAV5-ChR2-mCherry was injected into either the cortex or thalamus 
of neonatal mice. At P14–P16, AAV5-Cre-GFP virus was injected into the dorsolateral 
striatum as described above. Injection coordinates are listed in the Supplemental 
Experimental Procedures.
Immunohistochemistry
P25–P31 mice were perfused transcardially. Brains were post-fixed in 4% paraformaldehyde 
overnight and sectioned at 30 μm. Sections were blocked for 1 hr at room temperature (RT) 
in BlockAid (Thermo Fisher Scientific) and incubated overnight at 4°C with antibodies 
against phosphorylated (Ser240/244) S6 ribosomal protein (1:800; catalog no. 5364S, Cell 
Signaling Technology), GFP (1:5,000; catalog no. ab13970, Abcam) and NeuN (1:800; 
catalog no. MAB377, Millipore). Sections were washed and incubated for 1 hr at RT with 
Alexa Fluor 633-, 488-, and 405-conjugated secondary antibodies (1:500; catalog nos. 
A-21070, A11039, and A-31553, Invitrogen). Sections were mounted onto slides using 
ProLong Gold antifade reagent (Invitrogen).
Imaging and Analysis
Z stack images were taken on a confocal microscope (Olympus Fluoview FV1000) with a 
203 objective using the same exposure and acquisition settings for each section. To quantify 
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p-S6 levels and soma volume, regions of interest (ROIs) were automatically generated in 
Imaris software based on the NeuN or D2-GFP signal. The mean p-S6 fluorescence intensity 
per ROI and average soma volume were calculated using Imaris.
Dendrite Morphology Reconstruction
For anatomical reconstruction, 4 mg/mL neurobiotin was included in the internal solution 
during whole-cell recordings. Slices were recovered and fixed in 4% paraformaldehyde for 
24–48 hr. After washes in PBS, slices were reacted with 1:750 streptavidin-Alexa Fluor 633 
(Invitrogen) for 1 h. Sections were then washed and coverslipped using ProLong Gold 
antifade reagent. Dendrite arborization was quantified using 3D Sholl analysis in Imaris 
software. For dendritic spine analysis, proximal (50 μm from soma) and distal (100 μm from 
soma) dendrites were imaged on a Zeiss LSM 880 NLO AxioExaminer with Airyscan. 
Dendrites and spines were reconstructed in three dimensions and analyzed in Imaris.
Electrophysiology
Mice were perfused transcardially with ice-cold ACSF (pH 7.4) containing 127 mM NaCl, 
25 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, and 25 
mM glucose. Brains were rapidly removed, and coronal slices (275 μm) were cut on a 
VT1000S vibrotome (Leica) in oxygenated ice-cold choline-based external solution (pH 7.8) 
containing 110 mM choline chloride, 25 mM NaHCO3, 1.25 mM NaHPO4, 2.5 mM KCl, 7 
mM MgCl2, 0.5 mM CaCl2, 25 mM glucose, 11.6 mM sodium ascorbate, and 3.1 mM 
sodium pyruvate. Slices were recovered in ACSF at 34 C for 15 min and then kept at RT. 
Recordings were made with a MultiClamp 700B amplifier (Molecular Devices) at RT using 
3–5 MU glass patch electrodes. Current-clamp recordings were made using a potassium-
based internal solution (pH 7.4) containing 135 mM KMeSO4, 5 mM KCl, 5 mM HEPES, 4 
mM Mg-ATP, 0.3 mM Na-GTP, 10 mM phosphocreatine, and 1 mM EGTA. Voltage-clamp 
recordings were made using a cesium-based internal solution (pH 7.4) containing 120 mM 
CsMeSO4, 15 mM CsCl, 10 mM TEA-Cl, 8 mM NaCl, 10 mM HEPES, 0.2–5 mM EGTA, 5 
mM QX-314, 4 mM Mg-ATP, and 0.3 mM Na-GTP. For eIPSC experiments, recordings 
were made using a high chloride cesium-based internal solution (pH 7.2) to maximize IPSC 
amplitude, containing 125 mM CsCl, 10 mM TEA-Cl, 10 mM HEPES, 4 mM Mg-ATP, 0.3 
mM Na-GTP, 8 mM Na2CrePO4, 0.1 mM EGTA, and 3.3 mM QX-314. For experiments 
measuring synaptic currents, cells were held at −80 mV, and recordings were acquired with 
the amplifier’s Bessel filter set at 3 kHz.
Statistical Analyses
Two-tailed paired or unpaired t tests were used for comparisons between two groups. A one-
way ANOVA with Sidak’s post hoc test was used to compare the means of three or more 
groups. A two-way ANOVA with Sidak’s post hoc test was used to compare mean 
differences between groups for experiments with two independent variables. p values were 
corrected for multiple comparisons. For data that did not pass the D’Agostino and Pearson 
normality test, the Kruskal-Wallis with Dunn’s post hoc test was used. Cumulative 
distributions were analyzed using the K-S test. Values for all statistical comparisons are 
provided in Tables S1–S4.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Postnatal loss of Tsc1 causes hyperexcitability of dSPNs but not iSPNs
• Tsc1 KO dSPNs have altered somatic and dendritic morphology
• Tsc1 KO dSPNs have increased excitatory synaptic drive with no change in 
inhibition
• Corticostriatal transmission is selectively enhanced onto Tsc1 KO dSPNs
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Figure 1. Mosaic Loss of Tsc1 from Striatal Neurons Induces mTORC1 Activation and Somatic 
Hypertrophy
(A) Schematic showing the four cell types present in each striatal slice of a Tsc1fl/fl;D2-GFP 
mouse injected with AAV5-Cre-mCherry. iSPNs are identified by GFP fluorescence, and 
Tsc1 KO neurons are identified by nuclear mCherry expression.
(B–F) Confocal images of a striatal section showing NeuN immunostaining (B), D2-GFP 
fluorescence (C), Cre-mCherry fluorescence (D), phosphorylated S6 immunostaining (p-S6, 
Ser240/244) (E), and a merged image (F). Red arrows show Tsc1 KO dSPNs, yellow arrows 
show Tsc1 KO iSPNs, grey arrowheads indicate WT dSPNs and green arrowheads indicate 
WT iSPNs.
(G and H) Cumulative distributions of p-S6 levels (G) and soma volume (H) for neurons of 
each genotype. n = 300 neurons per genotype from 3 mice, 100 neurons per mouse. ***p < 
0.0001, K-S test; red stars indicate significance for dSPN KO versus dSPN WT, yellow stars 
denote significance for iSPN KO versus iSPN WT, and green stars indicate significance for 
dSPN WT versus iSPN WT.
See also Figure S1.
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Figure 2. Postnatal Loss of Tsc1 Increases the Intrinsic Excitability of dSPNs
(A) Example traces showing action potentials evoked by a 250 pA current step for each cell 
type. The resting membrane potential is indicated to the left of each trace.
(B) Frequency-current relationship for control (WT) and Tsc1 KO dSPNs and iSPNs, 
displayed as mean ± SEM. Two-way ANOVA p values are shown. p values for Sidak’s post 
hoc tests are in Table S1. dSPN WT n = 18 neurons from 15 mice, dSPN KO n = 21 neurons 
from 14 mice, iSPN WT n = 18 neurons from 16 mice, and iSPN KO n = 17 neurons from 
13 mice.
(C) Bar graph shows the mean ± SEM rheobase for each condition. Dots indicate the values 
for individual neurons. *p < 0.05 and ***p < 0.001, one-way ANOVA with Sidak’s post hoc 
test (see Table S2 for all p values); dSPN WT n = 17 neurons from 15 mice, dSPN KO n = 
16 neurons from 13 mice, iSPN WT n = 18 neurons from 16 mice, and iSPN KO n = 17 
neurons from 13 mice.
(D) Example traces of inward-rectifying potassium channel currents in dSPNs and iSPNs. 
Kir channel currents were obtained by applying negative voltage steps to the membrane 
(−150 to −60 mV in 10 mV increments) in the presence and absence of 1 mM CsCl. The 
cesium-sensitive component (IKir) was revealed using digital subtraction.
(E) Quantification of IKir at different membrane potentials across genotypes.
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Data are represented as mean ± SEM. Two-way ANOVA p values are shown. p values for 
the Sidak’s post hoc tests are in Table S2. dSPN WT n = 10 neurons from 10 mice, dSPN 
KO n = 10 neurons from 8 mice, iSPN WT n = 10 neurons from 10 mice, and iSPN KO n = 
9 neurons from 9 mice.
See also Figure S1.
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Figure 3. Tsc1 KO dSPNs Have Reduced Dendritic Arborization
(A) Example three-dimensional (3D) reconstructions of neurobiotin-filled SPNs of each 
condition. (B and C) Three-dimensional Sholl analysis of dSPN
(B) and iSPN (C) dendritic arbors. Circles of increasing radii were drawn at 1 μm intervals 
from the center of the soma and the number of dendrite crossings was quantified for each 
condition. Black lines indicate the mean and shaded regions show the SEM. Two-way 
ANOVA p values are shown for (B) and (C) combined (see also Table S1).
(D–F) Mean ± SEM of the total dendrite length (D), number of primary dendrites (E), and 
number of dendrite branch points (F) per neuron quantified by 3D Sholl analysis for each 
condition.
Dots indicate the values for individual neurons. *p < 0.05, Kruskal-Wallis with Dunn’s post 
hoc test (total dendrite length and number of branch points; see Table S3 for p values) and 
one-way ANOVA with Sidak’s post hoc test (number of primary dendrites; see Table S2 for 
p values). For all graphs, dSPN WT n = 22 neurons from 21 mice, dSPN KO n = 24 neurons 
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from 19 mice, iSPN WT n = 19 neurons from 19 mice, and iSPN KO n = 17 neurons from 
16 mice.
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Figure 4. Inhibitory Synaptic Transmission onto SPNs Is Not Affected by Loss of Tsc1
(A) Example traces of miniature inhibitory postsynaptic currents (mIPSCs) recorded from 
each cell type.
(B) Cumulative distribution of mIPSC amplitudes from neurons of each genotype.
(C) Mean ± SEM mIPSC amplitude per neuron for each genotype.
(D) Cumulative distribution of mIPSC inter-event intervals (IEIs) from neurons of each 
genotype.
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(E) Mean ± SEM mIPSC frequency per neuron. For (B)–(E), n = 200 mIPSCs per neuron, 
dSPN WT n = 10 neurons from 7 mice, dSPN KO n = 11 neurons from 8 mice, iSPN WT n 
= 10 neurons from 9 mice, and iSPN KO n = 11 neurons from 9 mice.
(F) Examples of simultaneously recorded IPSCs from pairs of Tsc1 WT and KO dSPNs and 
iSPNs, evoked by intra-striatal electrical stimulation.
(G and H) Graphs displaying the IPSC amplitude recorded from pairs of Tsc1 WT and KO 
dSPNs (G; n = 14 pairs from 10 mice) and iSPNs (H; n = 12 pairs from 10 mice).
(I) An AAV5-expressing Flp-dependent ChR2 was injected into the striatum of Tsc1fl/fl;D1-
tdTomato;Pvalb-2A-FlpO-D mice, followed by injection of AAV5-Cre-GFP. Paired 
recordings were made between Tsc1 WT and KO dSPNs, and PV-neuron inputs were 
activated by blue light stimulation.
(J) Examples of simultaneously recorded PV-IPSCs from a pair of Tsc1 WT and KO dSPNs, 
evoked by optogenetic stimulation. Blue line indicates light onset.
(K) Graph displaying the PV-IPSC amplitude recorded in pairs of Tsc1 WT and KO dSPNs, 
n = 6 pairs from 6 mice.
For all panels, dots indicate the values of individual neurons.
For (G), (H), and (K), the filled circles with error bars indicate the group mean ± SEM. See 
Tables S2 and S4 for p values for statistical comparisons.
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Figure 5. Excitatory Synaptic Transmission Is Increased in Tsc1 KO dSPNs
(A) Example traces of miniature excitatory postsynaptic currents (mEPSCs) recorded from 
each cell type.
(B) Cumulative distribution of mEPSC amplitudes from neurons of each genotype.
(C) Mean ± SEM mEPSC amplitude per neuron for each genotype.
(D) Cumulative distribution of mEPSC inter-event intervals (IEIs) from neurons of each 
genotype.
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(E) Mean ± SEM mEPSC frequency per neuron. *p < 0.05, one-way ANOVA with Sidak’s 
post hoc test. For (B)–(E), n = 200 mEPSCs per neuron, dSPN WT n = 14 neurons from 10 
mice, dSPN KO n = 14 neurons from 10 mice, iSPN WT n = 12 neurons from 8 mice, and 
iSPN KO n = 12 neurons from 8 mice.
(F) Examples of simultaneously recorded EPSCs from Tsc1 WT and KO pairs of dSPN and 
iSPNs evoked by intra-striatal electrical stimulation.
(G and H) Graphs displaying the EPSC amplitude recorded from pairs of Tsc1 WT and KO 
dSPNs (G; n = 22 pairs from 19 mice) and iSPNs (H; n = 11 pairs from 6 mice). **p < 0.01, 
paired t test. Filled circles with error bars indicate the group mean ± SEM.
(I) Example recordings of electrically evoked EPSCs from two stimuli delivered 50 ms 
apart.
(J and K) Mean ± SEM paired pulse ratio (PPR; defined as the amplitude of the second 
EPSC peak divided by the first) in Tsc1 WT and KO dSPNs (J; n = 21 cells from 19 mice) 
and iSPNs (K; n = 9 cells from 6 mice). *p < 0.05, unpaired t test.
For all panels, dots indicate the values of individual neurons. See Tables S2 and S4 for p 
values for statistical comparisons. See also Figure S2.
Benthall et al. Page 25
Cell Rep. Author manuscript; available in PMC 2018 August 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 6. Corticostriatal Synaptic Transmission Is Selectively Enhanced in Tsc1 KO dSPNs
(A) AAV5-ChR2-mCherry was injected into the thalamus of neonate Tsc1fl/fl;D1-tdTomato 
mice, followed by injection of AAV5-Cre-GFP into the dorsal striatum at P14–P16. 
Confocal image of a sagittal section showing ChR2-mCherry expression in the thalamus 
(arrow). DAPI staining is in blue.
(B) Examples of simultaneously recorded excitatory postsynaptic potentials (EPSPs) from a 
pair of Tsc1 WT and KO dSPNs, evoked by blue light stimulation of thalamostriatal 
terminals (blue line).
(C) Graph displaying thalamostriatal optogenetically evoked EPSP (oEPSP) amplitude 
recorded in pairs of Tsc1 WT and KO dSPNs, n = 8 pairs of neurons from five mice.
(D) AAV5-ChR2-mCherry was injected into the cortex of neonate Tsc1fl/fl;D1-tdTomato 
mice, followed by injection of AAV5-Cre-GFP into the dorsal striatum at P14–P16. 
Confocal image of a sagittal section showing ChR2-mCherry expression in the cortex 
(arrow). DAPI staining is in blue.
(E) Examples of simultaneously recorded EPSPs from a pair of Tsc1 WT and KO dSPNs, 
evoked by blue light stimulation of corticostriatal terminals (blue line).
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(F) Graph displaying corticostriatal oEPSP amplitude recorded in pairs of Tsc1 WT and KO 
dSPNs. *p < 0.05, paired t test; n = 9 pairs of neurons from eight mice.
(G) Tsc1fl/fl;D1-tdTomato;Thy1-ChR2-YFP mice were injected with AAV5-Cre-GFP, and 
recordings of light-evoked cortically driven action potentials (oAPs) were made from 
simultaneous pairs of Tsc1 WT and KO dSPNs.
(H) Examples of corticostriatal oAPs recorded over ten trials from a pair of Tsc1 WT and 
KO dSPNs. Blue line indicates light onset.
(I) Graph displaying the average spike latency per neuron for pairs of simultaneously 
recorded Tsc1 WT and KO dSPNs. Spike latency was defined as the time in milliseconds 
from the onset of blue light stimulation to the action potential threshold. *p < 0.05, paired t 
test.
(J) Graph displaying the spike jitter per neuron for pairs of simultaneously recorded Tsc1 
WT and KO dSPNs. Jitter was defined as the SD of the latency to action potential threshold 
for 4–11 stimulation trials per neuron. For (I) and (J), n = 9 pairs of neurons from nine mice.
For (C), (F), (I), and (J), dots indicate the values of individual neurons, and filled circles 
with error bars indicate the group mean ± SEM for paired recordings. See Table S4 for p 
values for statistical comparisons.
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